BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24452629)

  • 1. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.
    Fukushima S; Otsuka A; Suzuki T; Yanagisawa T; Mishima K; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Narita Y; Shibui S; Kato M; Shibata T; Matsutani M; Nishikawa R; Ichimura K;
    Acta Neuropathol; 2014; 127(6):911-25. PubMed ID: 24452629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit gene mutation: common and widely distributed in intracranial germinomas.
    Kamakura Y; Hasegawa M; Minamoto T; Yamashita J; Fujisawa H
    J Neurosurg; 2006 Mar; 104(3 Suppl):173-80. PubMed ID: 16572634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways.
    Schulte SL; Waha A; Steiger B; Denkhaus D; Dörner E; Calaminus G; Leuschner I; Pietsch T
    Oncotarget; 2016 Aug; 7(34):55026-55042. PubMed ID: 27391150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas.
    Fukushima S; Yamashita S; Kobayashi H; Takami H; Fukuoka K; Nakamura T; Yamasaki K; Matsushita Y; Nakamura H; Totoki Y; Kato M; Suzuki T; Mishima K; Yanagisawa T; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Nagane M; Iuchi T; Yoshimoto K; Mizoguchi M; Tamura K; Sakai K; Sugiyama K; Nakada M; Yokogami K; Takeshima H; Kanemura Y; Matsuda M; Matsumura A; Kurozumi K; Ueki K; Nonaka M; Asai A; Kawahara N; Hirose Y; Takayama T; Nakazato Y; Narita Y; Shibata T; Matsutani M; Ushijima T; Nishikawa R; Ichimura K;
    Acta Neuropathol; 2017 Mar; 133(3):445-462. PubMed ID: 28078450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS Mutation in Pediatric Intracranial Germ Cell Tumors.
    Khaiman C; Techavichit P; Poparn H; Chiangthong K; Lauhasurayotin S; Sosothikul D; Shotelersuk K; Nantavithya C; Jakchairoongruang K; Amornfa J; Khongkhaduead E; Santisukwongchote S; Teerapakpinyo C; Shuangshot S
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3179-3185. PubMed ID: 36172682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-kit gene mutations in intracranial germinomas.
    Sakuma Y; Sakurai S; Oguni S; Satoh M; Hironaka M; Saito K
    Cancer Sci; 2004 Sep; 95(9):716-20. PubMed ID: 15471556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Kit and Etv1 in restricted brain regions supports a brain-cell progenitor as an origin for cranial germinomas.
    Tan C; Scotting P
    Cancer Genet; 2015 Mar; 208(3):55-61. PubMed ID: 25736805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-kit expression in germinoma: an immunohistochemistry-based study.
    Nakamura H; Takeshima H; Makino K; Kuratsu J
    J Neurooncol; 2005 Nov; 75(2):163-7. PubMed ID: 16132509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel somatic and germline mutations in intracranial germ cell tumours.
    Wang L; Yamaguchi S; Burstein MD; Terashima K; Chang K; Ng HK; Nakamura H; He Z; Doddapaneni H; Lewis L; Wang M; Suzuki T; Nishikawa R; Natsume A; Terasaka S; Dauser R; Whitehead W; Adekunle A; Sun J; Qiao Y; Marth G; Muzny DM; Gibbs RA; Leal SM; Wheeler DA; Lau CC
    Nature; 2014 Jul; 511(7508):241-5. PubMed ID: 24896186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.
    Lindsay H; Huang Y; Du Y; Braun FK; Teo WY; Kogiso M; Qi L; Zhang H; Zhao S; Mao H; Lin F; Baxter P; Su JM; Terashima K; Perlaky L; Chintagumpala M; Adesina A; Lau CC; Williams Parsons D; Li XN
    J Neurooncol; 2016 May; 128(1):47-56. PubMed ID: 26956263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors.
    Miyanohara O; Takeshima H; Kaji M; Hirano H; Sawamura Y; Kochi M; Kuratsu J
    J Neurosurg; 2002 Jul; 97(1):177-83. PubMed ID: 12134909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of p53 gene mutation using a microdissection technique in primary intracranial germ cell tumors.
    Kim SK; Cho BK; Paek SH; Hong SJ; Kim HS; Hong SY; Choe G; Chi JG; Nam DH; Wang KC
    Int J Oncol; 2001 Jan; 18(1):111-6. PubMed ID: 11115546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
    Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
    Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors.
    Okada Y; Nishikawa R; Matsutani M; Louis DN
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):531-8. PubMed ID: 12071636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization in pineal germ cell tumors.
    Rickert CH; Simon R; Bergmann M; Dockhorn-Dworniczak B; Paulus W
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):815-21. PubMed ID: 11005262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
    Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
    Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors.
    Huang X; Zhang R; Mao Y; Zhou LF; Zhang C
    World J Pediatr; 2016 Aug; 12(3):275-282. PubMed ID: 27351562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.
    Knobbe CB; Reifenberger J; Reifenberger G
    Acta Neuropathol; 2004 Dec; 108(6):467-70. PubMed ID: 15517309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.